When the research of Professor Ian Frazer and the late Dr Jian Zhou at The University of Queensland (UQ) led to a vaccine for the virus that causes 70 percent of all cervical cancer cases, they knew their work was going to be transformative. Since its release 10 years ago, the Gardasil® vaccine, which is designed to protect both women and men against the Human Papilloma Virus (HPV), has led to a 90 percent reduction in HPV infection rates in countries with high levels of immunisation.